Ajooni Biotech Limited — Board Meeting, 19-04-2025: Outcome of Board Meeting

The Board of Directors of Ajooni Biotech Limited has approved the withdrawal of the offer for preferential warrants, which included the issuance of up to 5 crore convertible warrants at a price of ₹9 each, totaling ₹45 crore. Additionally, the board appointed M/s. SDK & Associates as the Secretarial Auditor and M/s. N. Kumar & Company as Internal Auditors for the financial year 2024-25, enhancing the company's governance and compliance framework.